The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Regeneron Pharmaceuticals, Inc’s current trading price is -53.03% away from its 52-week high, while its distance from the 52-week low is 8.16%. The stock’s price range for this period has been between $525.99 and $1211.20 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.62 million for the day, a number notably higher than the average daily volume of 1.01 million over the last three months.
Regeneron Pharmaceuticals, Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $1211.20 on 08/27/24, while the lowest value for the same period was recorded at $525.99 on 04/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Regeneron Pharmaceuticals, Inc (REGN) has experienced a quarterly decline of -17.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 61.88B and boasts a workforce of 15106 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 675.86, with a change in price of -193.43. Similarly, Regeneron Pharmaceuticals, Inc recorded 977,112 in trading volume during the last 100 days, posting a change of -25.37%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for REGN stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.10.
REGN Stock Stochastic Average
As of today, Regeneron Pharmaceuticals, Inc’s raw stochastic average for the last 50 days stands at 19.31%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 37.24%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 58.80% and 62.13%, respectively.
REGN Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -20.13%. However, over the last six months, the performance has been stronger by -38.75%. The price of REGN decreased -10.74% over the last 30 days. And in the last five days, it has fallen by -2.83%.
